Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specific Use-Result Surveillance of Spiriva Respimat in Asthmatics (Patients With Mild and Moderate Persistent Asthma)

NCT03188120 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03188120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specific Use-Result Surveillance of Spiriva Respimat in Asthmatics (Patients With Mild and Moderate Persistent Asthma)
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
July 4, 2017
Completion date
November 8, 2018
Enrollment
193 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma